The Murky World of PBMs

Why This Topic Matters

It helps readers understand why pharmacy prices can be difficult to predict and why payer, manufacturer, and intermediary relationships matter to patients, clinicians, and health system leaders.

Article Sections

1. Pharmacy benefit managers and drug pricing

   An overview of how pharmacy benefit managers fit into the medication distribution and financing system. The section focuses on the broader market relationships that can affect patient costs and access.

2. The FDA

   A discussion of how a federal regulatory action and subsequent market changes are presented as part of the pricing story. The section frames one example of how policy and product status can influence the marketplace.

3. The future?

   A brief look at expected change in drug pricing and market structure. The section references industry consolidation and broader shifts in care delivery.